Please login to the form below

Not currently logged in
Email:
Password:

NDA Group appoints Alison McGregor as its principal consultant

She joins the group following a new US office launch

Drug development consultancy, NDA Group, has appointed Alison McGregor as its principal consultant following the opening of its new US office in San Francisco.

McGregor joins the group from BioMarin Pharmaceuticals, where she was previously global regulatory affairs leader.

She has over 20 years’ experience in the pharmaceutical sector working for both industry and regulatory agencies including AstraZeneca and the UK’s MHRA.

Johan Stromquist, chief executive officer, NDA Group, said: “The US expansion is our main focus in 2018 and we are planning expanding our support for FDA and EMA submissions, milestone meetings and de-risking early stage data packages.

“Bringing Alison on-board is particularly important as her experience represents the ideal we share across NDA – that of bringing diverse regulatory requirements together to create the best possible development programmes as efficiently as possible.”

24th November 2017

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics